Mobile Apheresis Inc Fort Lauderdale, FL - 33331

Mobile Apheresis Inc is categorized under Therapeutic X-Ray Apparatus and Tubes in Fort Lauderdale, FL and active since 2000.

Mobile Apheresis Inc was established in 2000, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Therapeutic X-Ray Apparatus and Tubes business, which does work in the B2B market, and is classified as a Therapeutic X-Ray Apparatus and Tubes, under code number 334517 by the NAICS.

If you are seeking more information, feel free to contact Debra M Ellison at the company’s single location by writing to 5730 Sw 166th Avenue, Fort Lauderdale, Florida FL 33331 or by phoning (954) 483-3623. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Mobile Apheresis Inc
Contact Person: Debra M Ellison
Address: 5730 Sw 166th Avenue, Fort Lauderdale, Florida 33331
Phone Number: (954) 483-3623
Annual Revenue (USD): $100.000 to $499.999
Founded: 2000
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Therapeutic X-Ray Apparatus and Tubes
SIC Code: 3844
NAICS Code: 334517
Share This Business:

Mobile Apheresis Inc was started in 2000 to provide professional Therapeutic X-Ray Apparatus and Tubes under the SIC code 3844 and NAICS code 334517. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Debra M Ellison for inquiries that concern Mobile Apheresis Inc by calling the company number (954) 483-3623, as your correspondence is most welcome. Additionally, the physical location of the single location of Mobile Apheresis Inc can be found at the coordinates 26.045292,-80.369438 as well as the street address 5730 Sw 166th Avenue in Fort Lauderdale, Florida 33331.

For its online presence, you may visit Mobile Apheresis Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.